SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950142-23-000537
Filing Date
2023-02-28
Accepted
2023-02-28 16:16:14
Documents
1
Group Members
GAP (BERMUDA) L.P.GAP COINVESTMENTS CDA, L.P.GAP COINVESTMENTS III, LLCGAP COINVESTMENTS IV, LLCGAP COINVESTMENTS V, LLCGENERAL ATLANTIC (CIN), L.P.GENERAL ATLANTIC (LUX) S.A R.L.GENERAL ATLANTIC (SPV) GP, LLCGENERAL ATLANTIC GENPAR (BERMUDA), L.P.GENERAL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 eh230332690_13da2-cincor.htm SC 13D/A 239232
  Complete submission text file 0000950142-23-000537.txt   241712
Mailing Address 55 EAST 52ND STREET 33RD FLOOR NEW YORK NY 10055
Business Address 55 EAST 52ND STREET 33RD FLOOR NEW YORK NY 10055 212 715 4000
GENERAL ATLANTIC, L.P. (Filed by) CIK: 0001017645 (see all company filings)

IRS No.: 133503735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Subject) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93228 | Film No.: 23685560
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences